Insulin

More documents

Recommendations

Info

Incretins: augment insulin secretionGive a glucose loadIV or oralMatch glycemic profile intravenousor oral with glucose load“Incretins”•GLP-1 (7-36)•GIP•? Other incretinsPlasma glucoseIVoralWith oral glucose loadPlasma <strong>Insulin</strong>With intravenousglucose loadTime
The Main Incretin• GIP (Glucose-dependent <strong>Insulin</strong>otropicPeptide)• GLP (Glucagon Like Peptide)
Page 6 and 7: Milestones for Management of Diabet
Page 8 and 9: GLOBAL PROJECTIONS FORTHE DIABETES
Page 10 and 11: ILLNESS• Absence of symptoms• I
Page 13 and 14: UKPDS demonstrated loss of glycemic
Page 15 and 16: UKPDS 35 - Association of glycemia
Page 17 and 18: Lessons from the UKPDS• Too few p
Page 19 and 20: Stages to reach and maintain thetar
Page 21 and 22: Oral antidiabetic agents:physiologi
Page 23 and 24: OHA FOR DIABETESClassEfficacy in Hb
Page 25 and 26: A consensus statement from theAmeri
Page 27: New Treatment• GLP-1• Amylin an
Page 31 and 32: GLP-1: regulation and actionsDelaye
Page 33: What does GLP-1 1 do?• Enhance in
Page 36 and 37: Correlation between HbA1c & Plasma
Page 38 and 39: Target for ControlRisk versus benef
Page 40 and 41: • Individualised risk assessment
Page 42 and 43: Steno -2: Microvascular complicatio
Page 44 and 45: Fundamental message• Diabetes man
Page 46 and 47: DOCTORS FACTORS• Not listening to
Page 48 and 49: MULTIDISCIPLINARY CARE• Self care
Page 50: MULTIDISCIPLINARY CARE• Diabetes
Page 53: InterventionsExpecteddecrease inHbA

Insulin

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?